ArticleNature communications2024

Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.

Sara De Biasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.